DCM
GMED icon

Defilade Capital Management’s Globus Medical GMED Stock Holding History

Defilade Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Sell
139,637
-214,713
-61% -$18.2M 1.48% 28
2026
Q1 		$30.5M Buy
354,350
+87,138
+33% +$7.82M 4.29% 10
2025
Q4 		$23.3M Buy
+267,212
New +$20.3M 3.16% 14

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Defilade Capital Management's GMED Position: Q2 2026 in Review

Defilade Capital Management reduced its Globus Medical (GMED) stake by 61% in Q2 2026, selling an estimated $18.2M and leaving 139,637 shares worth $11M. The position accounts for 1.48% of the portfolio, ranked #28.

Defilade Capital Management first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $30.5M in Q1 2026. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Defilade Capital Management held 139,637 shares of Globus Medical worth $11M as of Q2 2026.
  • Defilade Capital Management sold 214,713 Globus Medical shares in Q2 2026, an estimated $18.2M.
  • Globus Medical made up 1.48% of Defilade Capital Management's portfolio in Q2 2026, its #28 holding.
  • Defilade Capital Management first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Defilade Capital Management's Globus Medical position peaked at $30.5M in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Defilade Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.